what are the names of blood pressure medications being recalled?
436601
The recall comes amid a larger string of recalls of blood pressure medications valsartan, losartan and irbesartan that contain trace levels of carcinogens NMBA, N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), the FDA says. Hundreds of lots of the medication have been recalled since last July.
783752
Not all valsartan products are included in the recall. The FDA has traced the recalled drugs to Chinese manufacturers Zhejiang Huahais and Zhejiang Tianyu as well as Hetero Labs Limited in India.
21295
Aurobindo Pharma, Lupin recall drugs in US market. It is also recalling certain lots of Amlodipine and Valsartan Tablets USP 10mg/160mg in 30 count bottles for CGMP deviations. ... It is also recalling certain lots of Amlodipine and Valsartan Tablets USP 10mg/160mg in 30 count bottles for CGMP deviations.
148558
Dr. Reddy's Laboratories Ltd is voluntary recalling all prescription and over-the-counter (OTC) ranitidine tablets and capsules manufactured by the company. The OTC medicines may be labeled by retailers such as Walgreens, Walmart, CVS, Target, and Kroger.
871725
['Diuretics, also called water pills. ... ', 'Angiotensin-converting enzyme (ACE) inhibitors. ... ', 'Angiotensin II receptor blockers (ARBs). ... ', 'Calcium channel blockers. ... ', 'Beta blockers. ... ', 'Renin inhibitors.']
1078318
April 2020 update: The FDA has recalled all over-the-counter and prescription forms of ranitidine, which includes Zantac. If you take ranitidine, contact your health care provider to discuss other treatment options.
136575
Medications containing only amlodipine or HTCZ are not being recalled. Clinicians should be aware that not all lots of valsartan, irbesartan and losartan products are being recalled, and other ARBs, including candesartan, eprosartan, olmesartan and telmisartan, have not been recalled.
121869
The FDA has requested all ranitidine (Zantac) products be pulled from the market immediately, according to a statement. The recall includes all prescription and over-the-counter ranitidine drugs as ongoing investigations uncovered levels of N-Nitrosodimethylamine (NDMA), a probable human carcinogen, increase over time.
1330719
Update [7/27/2018] On July 13th, FDA announced a recall of certain batches of valsartan tablets because of an impurity, a chemical known as N-nitrosodimethylamine (NDMA). Valsartan is a medication commonly used to treat high blood pressure and heart failure.
69543
A drug company on Friday announced the recall of eight more lots of irbesartan blood pressure medication after testing revealed the drugs contained trace amounts of a carcinogen. Prinston Pharmaceuticals recalled one lot of irbesartan tablets and seven lots of irbesartan HCTZ tablets.
61117
Teva Pharmaceuticals has issued a voluntary recall of its amlodipine/valsartan combination tablets and amlodipine/valsartan/hydrochlorothiazide combination tablets, both used to treat high blood pressure, according to the FDA. The FDA announced the recall on its website Tuesday.
611118
Irbesartan. In July, the FDA announced a voluntary recall of irbesartan tablets. See which products were affected by the recall. In January 2019, Prinston Pharmaceutical Inc., doing business as Solco Healthcare LLC, voluntarily recalled eight llots of irbersartan-based drugs.
157546
['Diuretics.', 'Beta-blockers.', 'ACE inhibitors.', 'Angiotensin II receptor blockers.', 'Calcium channel blockers.', 'Alpha blockers.', 'Alpha-2 Receptor Agonists.', 'Combined alpha and beta-blockers.']
873040
['ACE inhibitors – such as enalapril, lisinopril, perindopril and ramipril.', 'angiotensin-2 receptor blockers (ARBs) – such as candesartan, irbesartan, losartan, valsartan and olmesartan.', 'calcium channel blockers – such as amlodipine, felodipine and nifedipine or diltiazem and verapamil.']
1238299
Blood Pressure Drug Recalled. Teva Pharmaceuticals USA is recalling 181,456 bottles of olmesartan medoxomil and hydrochlorothiazide tablets, 40 mg/25 mg, after samples failed to meet dissolution specifications, according to the January 23, 2019, US Food and Drug Administration (FDA) Enforcement Report.
804311
Update [8/20/2018] FDA is alerting health care professionals and patients that Torrent Pharmaceuticals Limited is voluntarily recalling 14 lots of valsartan/amlodipine/hydrochlorothiazide (HCTZ) tablets.
992567
Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited ...